Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 74 citing articles:

Wilson Disease: Copper-Mediated Cuproptosis, Iron-Related Ferroptosis, and Clinical Highlights, with Comprehensive and Critical Analysis Update
Rolf Teschke, Axel Eickhoff
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 9, pp. 4753-4753
Open Access | Times Cited: 17
Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types
Rolf Teschke
Journal of Clinical and Translational Hepatology (2025) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
Joseph Clinton, Sara Kiparizoska, Soorya Aggarwal, et al.
Drug Safety (2021) Vol. 44, Iss. 11, pp. 1125-1149
Open Access | Times Cited: 65
Drug induced liver injury – a 2023 update
Rebecca Allison, Asha Guraka, Isaac Thom Shawa, et al.
Journal of Toxicology and Environmental Health Part B (2023) Vol. 26, Iss. 8, pp. 442-467
Open Access | Times Cited: 38
Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method
Rolf Teschke, Nahúm Méndez‐Sánchez, Axel Eickhoff
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4828-4828
Open Access | Times Cited: 37
Copper, Iron, Cadmium, and Arsenic, All Generated in the Universe: Elucidating Their Environmental Impact Risk on Human Health Including Clinical Liver Injury
Rolf Teschke
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6662-6662
Open Access | Times Cited: 12
Epidemiology and Management of Drug-induced Liver Injury: Importance of the Updated RUCAM
Takashi Kobayashi, Michihiro Iwaki, Asako Nogami, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 19
Persistent hepatocyte secretory failure in lopinavir/ritonavir related to drug-induced liver injury: a case report
Yue Sun, Ran Wang, C.L. Wang, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Drug-induced liver injury secondary to tamoxifen
Deloshaan Subhaharan, Grace Murphy, Natalie Commins, et al.
Drug and Therapeutics Bulletin (2025), pp. dtb.2025.260098rep-dtb.2025.260098rep
Closed Access
Acute Liver Failure Due to Assumed Drug Induced Liver Injury but Lack of Any Validated Causality Algorithm: Evidence by 36 Cohort Reports with 21,709 Cases
Rolf Teschke, Axel Eickhoff
OBM Transplantation (2025) Vol. 09, Iss. 01, pp. 1-10
Open Access
Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification
Rolf Teschke
Livers (2025) Vol. 5, Iss. 1, pp. 8-8
Open Access
Idiosyncratic Drug-Induced Liver Injury (DILI) and Herb-Induced Liver Injury (HILI): Diagnostic Algorithm Based on the Quantitative Roussel Uclaf Causality Assessment Method (RUCAM)
Rolf Teschke, Gaby Danan
Diagnostics (2021) Vol. 11, Iss. 3, pp. 458-458
Open Access | Times Cited: 37
Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update
Rolf Teschke, Vongdala Noudeng, Nguyen Van Quan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10419-10419
Open Access | Times Cited: 32
Treatment of Drug-Induced Liver Injury
Rolf Teschke
Biomedicines (2022) Vol. 11, Iss. 1, pp. 15-15
Open Access | Times Cited: 26
Advances in Idiosyncratic Drug-Induced Liver Injury Issues: New Clinical and Mechanistic Analysis Due to Roussel Uclaf Causality Assessment Method Use
Rolf Teschke, Gaby Danan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10855-10855
Open Access | Times Cited: 13
Human Leucocyte Antigen Genetics in Idiosyncratic Drug-Induced Liver Injury with Evidence Based on the Roussel Uclaf Causality Assessment Method
Rolf Teschke, Gaby Danan
Medicines (2024) Vol. 11, Iss. 4, pp. 9-9
Open Access | Times Cited: 4
A dual-response fluorescent probe to reveal the role of ferroptosis in drug-induced liver injury
Jianfei Liu, Changyi Li, Junmin Sun, et al.
Chemical Engineering Journal (2024) Vol. 495, pp. 153592-153592
Closed Access | Times Cited: 4
Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies
Rolf Teschke, Gaby Danan
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3441-3441
Open Access | Times Cited: 30
Herb-Induced Liver Injury—A Challenging Diagnosis
David Ricardo da Conceição Marçal Alves Nunes, Cristina Monteiro, Jorge Luiz dos Santos
Healthcare (2022) Vol. 10, Iss. 2, pp. 278-278
Open Access | Times Cited: 18
Molecular and Antioxidant Characterization of Opuntia robusta Fruit Extract and Its Protective Effect against Diclofenac-Induced Acute Liver Injury in an In Vivo Rat Model
Gloria Stephanie Villa-Jaimes, Han Moshage, Francisco Javier Avelar-González, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 113-113
Open Access | Times Cited: 10
Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations
Rolf Teschke
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6663-6663
Open Access | Times Cited: 10
Herbal and dietary supplement induced liver injury: Highlights from the recent literature
Stephanie Woo, William D. Davis, Soorya Aggarwal, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1019-1041
Open Access | Times Cited: 24
The LiverTox Paradox-Gaps between Promised Data and Reality Check
Rolf Teschke, Gaby Danan
Diagnostics (2021) Vol. 11, Iss. 10, pp. 1754-1754
Open Access | Times Cited: 23
Recent advance of fluorescent probes for detection of drug-induced liver injury markers
Dong-qin Sun, Zhenzhen Chen, Jiali Hu, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 10, pp. 4478-4494
Closed Access | Times Cited: 23
Liver injury during durvalumab-based immunotherapy is associated with poorer patient survival: A retrospective analysis
Linnea A. Swanson, Ihab Kassab, Irene Tsung, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Page 1 - Next Page

Scroll to top